The FDA approval was based on data from a Phase 3, multi-center, prospective, double-blind, randomized, placebo-controlled study in 381 adults treated with Dysport 1000 Units, Dysport 1500 Units or ...
Based on a triple blind study conducted by triple board certified, celebrity plastic surgeon Dr. Ramtin Kassir, a test of the efficacy and safety of popular injectables, brand named "Botox" and ...
When it comes to a scraped knee, you probably reach for a Band-Aid. Sneeze attack? Kleenex, please! Sometimes a brand is so good, so ubiquitous, that it defines an industry. The same could be said for ...
Crows' feet, frown lines, and forehead creases are all signs of a life full of facial expressions. And while some may be reminders of happy memories, it's also totally fine to want to smooth them away ...
Temporary side effects are possible. Among the most common are headache, pain at the injection site, and inflammation. More severe side effects can include nausea, eyelid drooping, and muscle weakness ...
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced results from new analyses of pivotal Phase III clinical trial data to assess treatment intervals over repeat cycles ...
When contracting the muscles on their faces after a cosmetic procedure around their eyes, the majority of patients and doctors commented that Dysport (abobotulinumtoxinA) fared better than Botox ...
Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently published in European Urology 1 CONTENT showed that Dysport ® decreased incontinence episodes, ...
Injections are becoming increasingly popular, and crowds of people are stepping over the fear of the needle to improve appearance. But, as is often the case with expensive products and services, ...
Competition has arrived for Irvine-based Allergan Inc.? blockbuster wrinkle-remover Botox, but Chief Executive David Pyott plans few changes in his marketing of the drug. At the end of April, Allergan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results